Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Carcinomatous Meningitis
Interventions: DRUG: Trastuzumab
Sponsor: Institut Curie
Collaborators: Hoffmann-La Roche|Centre Leon Berard|Groupe Hospitalier Pitie-Salpetriere|Centre Oscar Lambret|Centre Francois Baclesse|Institut Bergonié|University Hospital, Toulouse|Institut du Cancer de Montpellier - Val d'Aurelle|University Hospital, Grenoble